Regulation 5 Amendment of regulation 229

in paragraph (1), after “Regulations 214(1)” insert “and (2)”;

after paragraph (2), insert—

“(2A)

In relation to a medicinal product that is for parenteral administration, condition A only applies if the person who has given the written directions is an appropriate practitioner in relation to that medicinal product.”;

in paragraph (3)(f), after “is supplied” insert “, either an authorisation by the licensing authority on a temporary basis under regulation 174 or”; and

after paragraph (3), insert—

“(4)

The following cease to have effect on 1st April 2022—

(a)

in paragraph (1), “and (2)”; and

(b)

paragraph (2A).”.